Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies into Clinical Development

Society for Immunotherapy of Cancer (SITC)

Tuning the cell-cell distance via the non-signaling extracellular spacer domain of chimeric antigen receptors is critical for optimal activity

Frontiers in Molecular Medicine

Safety switch optimization enhances antibody-mediated elimination of CAR T cells

GeekWire

Biotech startups join AWS and other partners in open-source project to help design new proteins

Fred Hutch Cancer Center

Red Light, Green Light: Precise cell targeting with Co-LOCKR

Business Insider

Power players: These 12 young serial founders are building the next generation of biotech startups

BioCentury

Lyell spinout Outpace leverages de novo proteins to control cell and gene therapies

Forbes

Outpace Bio raises $30 Million to design next generation cell therapies

Globe Newswire

Creating next generation smart cell therapies: Outpace Bio receives $30 million in Series A funding led by ARTIS Ventures and Lyell Immunopharma Inc